Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Revenue (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 16 years of Revenue data on record, last reported at $36.4 million in Q2 2025.

  • For Q2 2025, Revenue fell 3.8% year-over-year to $36.4 million; the TTM value through May 2025 reached $128.9 million, changed 0.47%, while the annual FY2025 figure was $128.9 million, 0.47% changed from the prior year.
  • Revenue reached $36.4 million in Q2 2025 per LFCR's latest filing, up from $35.2 million in the prior quarter.
  • Across five years, Revenue topped out at $53.1 million in Q1 2022 and bottomed at $10.3 million in Q2 2022.
  • Average Revenue over 5 years is $31.2 million, with a median of $30.6 million recorded in 2023.
  • Peak YoY movement for Revenue: plummeted 77.15% in 2022, then surged 203.42% in 2023.
  • A 5-year view of Revenue shows it stood at $25.6 million in 2021, then decreased by 14.6% to $21.9 million in 2022, then surged by 37.9% to $30.2 million in 2023, then grew by 8.01% to $32.6 million in 2024, then rose by 11.91% to $36.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Revenue were $36.4 million in Q2 2025, $35.2 million in Q1 2025, and $32.6 million in Q4 2024.